Site icon OncologyTube

CAR-T Therapies will Dominate in 2018 Next Generation BTK Inhibitor data is still early

Elizabeth Brém, MD – HS Clinical Assistant Professor Chao Comprehensive Cancer Center discusses how CAR-T Therapies will Dominate in 2018 Next Generation BTK Inhibitor data is still early at MOASCs Spotlight On Hematology in Huntington Beach 2018.

Exit mobile version